Pfizer External Research & Grants (ER&G) (formerly Global Medical Grants & Partnerships) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s ER&G competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Date RFP Issued: JUL 18, 2025
Geographic Scope: Global (ex-US) with priority in Europe, Asia-Pacific region
Specific Area of Interest: Through this RFP it is our intent to support educational programs for HCPs that address knowledge gaps in identifying patients at high risk for developing severe COVID-19 outcomes, including hospitalization or death, and are designed to help achieve the following goals:
Improve identification of patients with high-risk conditions and their eligibility for COVID-19 treatment.
Recognize the importance of early COVID-19 intervention/treatment in high-risk patients.
Outline COVID-19 complications associated with high-risk conditions and the impact they have on patients and healthcare systems.
Long term impact of COVID-19, including long COVID and worsening or new onset of diseases (diabetes, Cardiovascular diseases).
Projects that use web based platforms and tools for educating HCPs in multiple countries will be considered. And thus platforms should support multiple languages/translations for HCPs from multiple countries.
